Navigation Links
Repligen Reports Second Quarter Fiscal Year 2009 Financial Results
Date:11/6/2008

signation by the FDA, a process designed to facilitate the development and expedite the review of drugs that treat serious diseases and fill an unmet medical need. There are more than 300,000 procedures conducted in the United States and Europe each year that may benefit from enhancement with RG1068.

RG2417 for Bipolar Disorder

We have initiated a Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial in which approximately 150 patients with bipolar depression will receive either RG2417 or a placebo twice a day for eight weeks. This study is designed to assess the efficacy and safety of RG2417 on the symptoms of depression as measured by the Montgomery-Asberg Depression Rating Scale (MADRS) and the Clinical Global Impression of Change in Bipolar Disorder scale (CGI-BP-C). This study is based on the positive results of a Phase 2a study in which 83 patients received either RG2417 or a placebo twice a day for six weeks. Over the six- week treatment period, the study demonstrated a statistically significant improvement in the symptoms of depression in the patients receiving RG2417 when compared to placebo on the MADRS (p=0.01) and the CGI-BP-C (p=0.04).

HDAC Inhibitors for Friedreich's Ataxia and Huntington's Disease

We are currently developing inhibitors of histone deacetylases (HDACs) which may have utility in treating progressive, inherited neurodegenerative diseases such as Friedreich's ataxia and Huntington's disease. We have identified several potential clinical candidates and are further characterizing these leads in animal models for their pharmacologic, toxicologic and pharmacodynamic profiles. Repligen announced receipt of a $1 million research grant from the Muscular Dystrophy Association and a $125,000 grant from the Friedreich's Ataxia Research Alliance and the National Ataxia Foundation. The grants
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
2. Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST
3. Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
4. Repligen Announces Share Repurchase Program
5. Repligen Announces Conference Call to Update Orencia(R) Lawsuit
6. Repligen Elects Earl Henry, M.D. to the Board of Directors
7. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
8. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
9. Stereotaxis Reports Third Quarter 2008 Financial Results
10. Volcano Reports 40 Percent Growth in Quarterly Revenues
11. Dialysis Corporation of America Reports Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Miraca Life Sciences, the nation’s largest independent anatomic ... pathology offering , to include critical testing for both ... pathology services feature:, Definitive diagnoses ... terminology and diagnostic criteria , Quantitative prognostic ... , Molecular tumor profiling , ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 ... independent freestanding emergency rooms in the United States, announced ... April. , “I am pleased to announce that ... Worth metroplex in Haslet,” said Dr. James M. Muzzarelli, ... , First Choice Emergency Room is revolutionizing the delivery ...
(Date:3/31/2015)... Buffalo, NY (PRWEB) March 31, 2015 ... been recognized by peers across the country for distinguished ... profession. The New York State Athletic Trainers’ Association ... extend congratulations to these NYS athletic trainers - especially ... (NATM)! The Ed Block Courage Award for ...
(Date:3/30/2015)... (PRWEB) March 31, 2015 A new ... aid patients and family members who may have been ... pregnancy for morning sickness. The site was created in ... of GlaxoSmithKline in C.A. No. 11-10398-RWZ, filed with the ... Toronto Star reports that this case alleged that ...
(Date:3/30/2015)... 31, 2015 NAPW honors ... Woman of the Year. Ms. Lucht is recognized with ... largest, most-recognized networking organization of professional women in the ... Association of Professional Women is a powerfully vibrant networking ... Chapters. , “Today’s managers need to have leadership skills ...
Breaking Medicine News(10 mins):Health News:Miraca Life Sciences Formalizes and Expands Breast Pathology Business 2Health News:Miraca Life Sciences Formalizes and Expands Breast Pathology Business 3Health News:First Choice Emergency Room to Open New Facility in Haslet, Texas 2Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 2Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 3Health News:Robert Gardner Law Announces Resource Site for Patients Prescribed Zofran During Pregnancy 2Health News:National Association of Professional Women Announces Winifred K. Lucht, Patient Financial Services Manager at Marshfield Clinic, a 2015 Professional Woman of the Year 2
... June 15 (HealthDay News) -- Being depressed doesn,t reduce ... finds. University of Michigan researchers analyzed data from ... and found that patients who were depressed or depression-free ... their excess weight within one year. They also reported ...
... Regionals 1st Middle-East & Africa Osteoporosis Meeting, to ... published its scientific programme at , http://www.iofbonehealth.org/dubai-2011/programme.html ... offering awards of 1000 USD each for the top ... age. The abstract deadline is June 17, 2011; all ...
... Researchers at the University of Toronto are the ... sleep disorder that has been closely linked to Parkinson,s ... the first to establish a potential genetic link to ... because between 60 and 80 per cent of people ...
... rock stars of the rodent world, the flashiest performers of ... the ladies, a University of Florida study shows. Neotropical ... a bravura performance attracts more interest from females, according to ... Animal Behaviour by doctoral candidate Bret Pasch and colleagues ...
... An evaluation of the Public Health Grid (PHGrid) technology ... capabilities of epidemiologists and disease-control agencies when the next ... the International Journal of Grid and Utility Computing ... Centers for Disease Control and Prevention, in Atlanta, Georgia, ...
... and women who get just six hours of sleep each night ... from the cumulative effects of this mild sleep deprivation, a new ... able to cope with and recover from this kind of sleep ... the weekend after a busy workweek associated with mild sleep loss ...
Cached Medicine News:Health News:Weight-Loss Surgery Can Be Effective Despite Depression 2Health News:Program announced for 1st Middle-East & Africa Osteoporosis Meeting 2Health News:Potential cause of severe sleep disorder discovered, implications for Parkinson's disease 2Health News:UF study: When singing mice choose a mate, a skillful song gets the gal 2Health News:UF study: When singing mice choose a mate, a skillful song gets the gal 3Health News:A grid approach to pandemic disease control 2Health News:Weekend Not Long Enough to Recover From Workweek Sleep Loss 2
(Date:3/30/2015)... Texas , March 30, 2015  Caris Life ... found drugs targeting specific pathways may have potentially significant ... cancer. The study results were highlighted today in an ... of Gynecologic Oncology (SGO) 2015 Annual Meeting on Women,s ... This study is one of four presented at ...
(Date:3/30/2015)... 2015 NiQ Health, "the ... the high level interface capabilities of their CarePlus™ ... The partnership between CarePlus™ and ClinicAll ... allows patients to choose the most appropriate alarm ... The advanced functionality of CarePlus™ allows patient alarms ...
(Date:3/30/2015)... 30, 2015 DURECT Corporation (Nasdaq: ... a multi-dose Phase 1 clinical trial of an ... DURECT,s Epigenomic Regulator Program.  DUR-928 is an endogenous, ... broad applicability in metabolic diseases such as nonalcoholic ...  It may also play an important role in ...
Breaking Medicine Technology:Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4
... (Nasdaq: MYL ) today commented on the death of ... Mylan Chairman and CEO Robert J. Coury said: "We ... one-of-a-kind individual. Mike was a pioneer in many ways and helped ... of us who knew Mike personally will always remember him as ...
... urging the U.S. Department of Health and Human Services ... affordable, flexible benefits in the exchanges, the Institute of ... and some powerful special interests that benefit from costly ... (PCMA). A new survey ...
Cached Medicine Technology:PCMA on IOM Essential Health Benefits Report: Employers and Special Interests Will Spar Over Costly Prescription Drug Mandates 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: